CY1120883T1 - Οφθαλμικο πηκτωμα βιματοπροστη χορηγουμενο σταγδην - Google Patents
Οφθαλμικο πηκτωμα βιματοπροστη χορηγουμενο σταγδηνInfo
- Publication number
- CY1120883T1 CY1120883T1 CY181101224T CY181101224T CY1120883T1 CY 1120883 T1 CY1120883 T1 CY 1120883T1 CY 181101224 T CY181101224 T CY 181101224T CY 181101224 T CY181101224 T CY 181101224T CY 1120883 T1 CY1120883 T1 CY 1120883T1
- Authority
- CY
- Cyprus
- Prior art keywords
- weight
- administrated
- temperature
- amount
- gel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Η εφεύρεση αναφέρεται σε ένα δυνάμενο να χορηγείται στάγδην οφθαλμικό πήκτωμα, το οποίο λεχθέν πήκτωμα έχει μία σύνθεση που περιέχει βιματοπρόστη σε ποσότητα 0.003 έως 0.03% κατά βάρος, πολυακρυλικό σε ποσότητα από 0.15 έως 0.7% κατά βάρος, ποβιδόνη (PVP), δεξτράνη, πολυαιθυλενογλυκόλες (PEG), καρβοξυμεθυλοκυτταρίνη (CMC) ή πολυ (βινυλική αλκοόλη) (PVA) σε ποσότητα από 0.2 έως 0.8% κατά βάρος, παράγοντα ισοτονισμού σε ποσότητα που παράγει οσμωτικότητα από 200 έως 400 mosml/kg, ένα άλας για ρύθμιση του ιξώδους σε ποσότητα από 0.05 έως 0.4% κατά βάρος, μία βάση σε ποσότητα για ρύθμιση του pΗ σε 6 έως 8 και έκδοχα που χρησιμοποιούνται κανονικά σε οφθαλμικά πηκτώματα.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15171233.8A EP3103439B1 (en) | 2015-06-09 | 2015-06-09 | Drippable ophthalmic bimatoprost gel |
| PCT/EP2016/062990 WO2016198434A1 (en) | 2015-06-09 | 2016-06-08 | Drippable ophthalmic bimatoprost gel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1120883T1 true CY1120883T1 (el) | 2019-12-11 |
Family
ID=53298285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY181101224T CY1120883T1 (el) | 2015-06-09 | 2018-11-20 | Οφθαλμικο πηκτωμα βιματοπροστη χορηγουμενο σταγδην |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US10314780B2 (el) |
| EP (2) | EP3103439B1 (el) |
| JP (1) | JP6342087B1 (el) |
| KR (1) | KR101889878B1 (el) |
| CN (1) | CN107771074B (el) |
| AU (1) | AU2016277336B2 (el) |
| BR (1) | BR112017026552B1 (el) |
| CA (1) | CA2985897C (el) |
| CY (1) | CY1120883T1 (el) |
| DK (1) | DK3307241T3 (el) |
| ES (2) | ES2747302T3 (el) |
| HK (1) | HK1247118A1 (el) |
| HR (1) | HRP20181840T1 (el) |
| IL (1) | IL256071B (el) |
| LT (1) | LT3307241T (el) |
| MA (1) | MA42290B1 (el) |
| MX (1) | MX2017015835A (el) |
| PL (2) | PL3103439T3 (el) |
| PT (1) | PT3307241T (el) |
| RS (1) | RS57948B1 (el) |
| RU (1) | RU2698456C2 (el) |
| SA (1) | SA517390480B1 (el) |
| SG (1) | SG11201708642VA (el) |
| SI (1) | SI3307241T1 (el) |
| TN (1) | TN2017000445A1 (el) |
| TR (1) | TR201815791T4 (el) |
| UA (1) | UA121139C2 (el) |
| WO (1) | WO2016198434A1 (el) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112566622A (zh) * | 2018-06-19 | 2021-03-26 | 细胞疗法有限责任公司 | 用于治疗青光眼或高眼压症的包含眼内压降低剂、cnp化合物、npr-b化合物、tie-2激动剂或神经营养剂的缓释药物递送*** |
| CN110200904B (zh) * | 2019-05-27 | 2021-07-23 | 上海昊海生物科技股份有限公司 | 一种降眼压缓释滴眼组合物及其制备方法 |
| US11786538B2 (en) | 2019-12-11 | 2023-10-17 | Somerset Therapeutics, Llc | Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties |
| US20230293541A1 (en) | 2022-03-21 | 2023-09-21 | Somerset Therapeutics, Llc | Methods of treating ophthalmic conditions with enhanced penetration compositions of bimatoprost and timolol |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4209722C3 (de) * | 1992-03-25 | 1997-06-19 | Medproject Pharma Entwicklungs | Tropfbares Gel für die Augenheilkunde |
| DE10132876A1 (de) * | 2001-07-06 | 2003-01-30 | Medproject Pharma Entwicklungs | Zweiphasige, tropfbare Hydrogele zur Anwendung am Auge |
| GB0501192D0 (en) * | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
| US7851504B2 (en) | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
| FR2918891B1 (fr) * | 2007-07-20 | 2009-09-25 | Thea Sa Lab | Solution ophtalmique a base de prostaglandines sans conservateur |
| EP2127638A1 (en) | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| FR2961694B1 (fr) * | 2010-06-29 | 2013-01-25 | Thea Lab | Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur |
| EP2598117A2 (en) | 2010-07-29 | 2013-06-05 | Allergan, Inc. | Preservative free bimatoprost solutions |
| EP2714007A2 (en) * | 2011-05-27 | 2014-04-09 | Ratiopharm GmbH | Ophthalmic preparation comprising a pgf2alpha analogue |
| CA2841969A1 (en) * | 2011-07-20 | 2013-01-24 | Allergan, Inc. | Fixed dose combination of bimatoprost and brimonidine |
| CN104288092A (zh) * | 2013-07-16 | 2015-01-21 | 广东东阳光药业有限公司 | 拉坦前列素滴眼剂 |
| CN104622798B (zh) * | 2014-12-05 | 2017-12-22 | 广东东阳光药业有限公司 | 一种含有他氟前列素的滴眼液及其制备方法 |
-
2015
- 2015-06-09 EP EP15171233.8A patent/EP3103439B1/en active Active
- 2015-06-09 ES ES15171233T patent/ES2747302T3/es active Active
- 2015-06-09 PL PL15171233T patent/PL3103439T3/pl unknown
-
2016
- 2016-06-08 MA MA42290A patent/MA42290B1/fr unknown
- 2016-06-08 KR KR1020177033703A patent/KR101889878B1/ko active IP Right Grant
- 2016-06-08 EP EP16729525.2A patent/EP3307241B8/en active Active
- 2016-06-08 DK DK16729525.2T patent/DK3307241T3/en active
- 2016-06-08 PL PL16729525T patent/PL3307241T3/pl unknown
- 2016-06-08 TR TR2018/15791T patent/TR201815791T4/tr unknown
- 2016-06-08 UA UAA201800181A patent/UA121139C2/uk unknown
- 2016-06-08 SI SI201630107T patent/SI3307241T1/sl unknown
- 2016-06-08 US US15/580,770 patent/US10314780B2/en active Active
- 2016-06-08 RS RS20181341A patent/RS57948B1/sr unknown
- 2016-06-08 SG SG11201708642VA patent/SG11201708642VA/en unknown
- 2016-06-08 TN TNP/2017/000445A patent/TN2017000445A1/en unknown
- 2016-06-08 CA CA2985897A patent/CA2985897C/en active Active
- 2016-06-08 PT PT16729525T patent/PT3307241T/pt unknown
- 2016-06-08 RU RU2017138099A patent/RU2698456C2/ru active
- 2016-06-08 WO PCT/EP2016/062990 patent/WO2016198434A1/en active Application Filing
- 2016-06-08 CN CN201680033806.8A patent/CN107771074B/zh active Active
- 2016-06-08 AU AU2016277336A patent/AU2016277336B2/en active Active
- 2016-06-08 JP JP2017557200A patent/JP6342087B1/ja active Active
- 2016-06-08 BR BR112017026552-4A patent/BR112017026552B1/pt active IP Right Grant
- 2016-06-08 LT LTEP16729525.2T patent/LT3307241T/lt unknown
- 2016-06-08 ES ES16729525T patent/ES2703432T3/es active Active
- 2016-06-08 MX MX2017015835A patent/MX2017015835A/es active IP Right Grant
-
2017
- 2017-12-03 IL IL256071A patent/IL256071B/en active IP Right Grant
- 2017-12-05 SA SA517390480A patent/SA517390480B1/ar unknown
-
2018
- 2018-05-25 HK HK18106817.8A patent/HK1247118A1/zh unknown
- 2018-11-06 HR HRP20181840TT patent/HRP20181840T1/hr unknown
- 2018-11-20 CY CY181101224T patent/CY1120883T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120883T1 (el) | Οφθαλμικο πηκτωμα βιματοπροστη χορηγουμενο σταγδην | |
| CY1122122T1 (el) | Υδατικο οφθαλμικο διαλυμα και μεθοδος για τη θεραπευτικη αγωγη συνδρομου ξηρου οφθαλμου | |
| EA201990169A1 (ru) | Диметоксифенилзамещенные соединения индола в качестве ингибиторов tlr7, tlr8 или tlr9 | |
| CY1123450T1 (el) | Μεθοδος καθαρισμου συζευγματων βασει il-15/il-15ra | |
| CY1120177T1 (el) | Φλαγκελλινη roseburia και ανοσορυθμιση | |
| CU20180062A7 (es) | Anticuerpos neutralizadores del virus de inmunodeficiencia humana | |
| MX2020005622A (es) | Compuestos de indol sustituidos con arilo y heteroarilo. | |
| MX2021001957A (es) | Compuestos de degradacion y metodos de uso del receptor de tropomiosina quinasa (trk). | |
| CY1120941T1 (el) | Παραγωγα φαινυλοτριαζολιου υποκατεστημενα με υδροξυαλκυλιο και χρησεις αυτων | |
| EA201891024A1 (ru) | Соединения-ингибиторы tank-связывающей киназы | |
| CO2018003863A2 (es) | Anticuerpos anti-vegf | |
| EA202090720A1 (ru) | ПРОИЗВОДНЫЕ GalNAc | |
| EA201692201A1 (ru) | Соединения и композиции в качестве агонистов toll-подобного рецептора 7 | |
| CY1122740T1 (el) | Ευτηκτικα σκευασματα υδροχλωρικης κυκλοβενζαπρινης και μαννιτολης | |
| EA201591420A1 (ru) | Гетероарильные соединения и их применение | |
| GEP20227447B (en) | Constructs having sirp-alpha domain or variant thereof | |
| CY1113642T1 (el) | Γεφυρωμενες δικυκλικες ετεροαρυλ υποκατεστημενες τριαζολες, χρησιμες ως αναστολεις της axl | |
| EA201591960A1 (ru) | Ингибиторы акк и их применение | |
| EA201691853A1 (ru) | Агонисты мускариновых рецепторов | |
| BR112013021486A2 (pt) | lentes de contato de hidrogel contendo fosfina | |
| EA201300080A1 (ru) | Дипиридильные производные, пригодные для лечения заболеваний, индуцированных киназами | |
| EA201692091A1 (ru) | Хиноксалиновые соединения и их применение | |
| EA201890800A1 (ru) | Соединения и композиции для лечения глазных расстройств | |
| EA202091477A1 (ru) | Замещенные соединения простых индольных эфиров | |
| CY1121000T1 (el) | Sirna και χρηση αυτου σε μεθοδους και συνθεσεις για την θεραπεια ή/και προληψη οφθαλμικων καταστασεων |